(firstQuint)Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice.

 The study will include 750 patients and will record data at 24 weeks.

 The study will also record data at 48 weeks for those patients whom these data are available.

 Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice@highlight

This is a retrospective observational study of patients who have taken a regimen containing DRV / c at least 24 weeks prior to study initiation